Reference health

The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?

https://doi.org/10.1186/1755-1536-7-4
CiteStamped reference-health badge
144/144 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

10 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 144 checked references that resolve
resolves10.1159/000313946
Renal Interstitial Fibrosis: A Critical Evaluation of the Origin of Myofibroblasts
resolves10.1126/scitranslmed.3004700
Therapy for Fibrotic Diseases: Nearing the Starting Line
resolves10.1093/ndt/gfm393
Treatment targets in renal fibrosis
resolves10.1007/s004670000461
Molecular basis of renal fibrosis
resolves10.1038/nrneph.2010.120
Renal fibrosis: novel insights into mechanisms and therapeutic targets
resolves10.1038/nrneph.2011.149
Cellular and molecular mechanisms of renal fibrosis
resolves10.1093/ndt/gfl691
PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis
resolves10.1111/j.1440-1681.2011.05487.x
Chronic kidney disease growth factors in renal fibrosis
resolves10.1172/JCI19375
Renal fibrosis: not just PAI-1 in the sky
resolves10.3892/ijmm.2013.1234
Plasminogen activator inhibitor-1 in kidney pathology
resolves10.1093/ndt/gfs296
The renal (myo-)fibroblast: a heterogeneous group of cells
resolves10.1038/nm.3218
Origin and function of myofibroblasts in kidney fibrosis
resolves10.1681/ASN.V7122495
Molecular insights into renal interstitial fibrosis.
resolves10.1097/MNH.0b013e3283521cfa
Renal interstitial fibrosis
resolves10.1086/597350
Assessment of Liver Fibrosis by Transient Elastography in Persons with Hepatitis C Virus Infection or HIV–Hepatitis C Virus Coinfection
resolves10.1097/RLI.0b013e31827a4990
Magnetic Resonance Elastography Noninvasively Detects In Vivo Renal Medullary Fibrosis Secondary to Swine Renal Artery Stenosis
resolves10.1038/ki.2011.198
Biomarkers in chronic kidney disease: a review
resolves10.2215/CJN.02560706
Can We Rely on Blood Urea Nitrogen as a Biomarker to Determine When to Initiate Dialysis?
resolves10.1046/j.1523-1755.2003.00840.x
Pathophysiology of proteinuria
resolves10.1038/ki.1995.40
Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine
resolves10.1093/glycob/7.4.499
Molecular characterization of β-trace protein in human serum and urine: a potential diagnostic marker for renal diseases
resolves10.1038/nbt0510-436
Next-generation biomarkers for detecting kidney toxicity
resolves10.1681/ASN.2005010076
Asymmetrical Dimethylarginine Predicts Progression to Dialysis and Death in Patients with Chronic Kidney Disease
resolves10.1159/000336109
Elevated Plasma Levels of Endostatin Are Associated with Chronic Kidney Disease
resolves10.1093/ndt/gfh701
The role of fibroblast growth factor 23 in renal disease
resolves10.1056/NEJMoa0706130
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
resolves10.1681/ASN.2010121224
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
resolves10.1001/jama.2011.826
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
resolves10.1038/ki.2012.176
Update on fibroblast growth factor 23 in chronic kidney disease
resolves10.1159/000104428
Messenger RNA Expression of Podocyte-Associated Molecules in the Urinary Sediment of Patients with Diabetic Nephropathy
resolves10.1159/000074322
Urinary Sediment Podocalyxin in Children with Glomerular Diseases
resolves10.2215/CJN.03530708
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease
resolves10.1002/jcp.24267
Kidney injury molecule‐1: More than just an injury marker of tubular epithelial cells?
resolves10.1002/path.2175
Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease
resolves10.1053/j.ajkd.2009.11.009
Early Urinary Markers of Diabetic Kidney Disease: A Nested Case-Control Study From the Diabetes Control and Complications Trial (DCCT)
resolves10.1016/S0009-8981(00)00237-0
Diagnostic value of urinary alanine aminopeptidase and N-acetyl-β-d-glucosaminidase in comparison to α1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients
resolves10.1016/j.lab.2003.08.001
Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal disease
resolves10.2337/dc09-2242
Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
resolves10.1016/j.transproceed.2008.10.088
Neutrophil Gelatinase-Associated Lipocalin Is a New and Sensitive Marker of Kidney Function in Chronic Kidney Disease Patients and Renal Allograft Recipients
resolves10.1038/nrneph.2013.108
Biomarkers for incident CKD: a new framework for interpreting the literature
resolves10.1053/j.ajkd.2012.05.014
Associations of Urinary Levels of Kidney Injury Molecule 1 (KIM-1) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) With Kidney Function Decline in the Multi-Ethnic Study of Atherosclerosis (MESA)
resolves10.1016/j.cca.2010.12.030
Increased total cytokeratin-18 serum and urine levels in chronic kidney disease
resolves10.1002/path.1437
Functional structure and composition of the extracellular matrix
resolves10.1016/j.trsl.2012.03.004
Glomerular basement membrane and related glomerular disease
resolves10.1681/ASN.2005121298
A Hypomorphic Mutation in the Mouse Laminin α5 Gene Causes Polycystic Kidney Disease
resolves10.2353/ajpath.2010.090570
Laminin α4-Null Mutant Mice Develop Chronic Kidney Disease with Persistent Overexpression of Platelet-Derived Growth Factor
resolves10.1093/ndt/15.12.1956
Abnormal expression of glomerular basement membrane laminins in membranous glomerulonephritis
resolves10.1097/01.ASN.0000130562.90255.8F
Mouse Model of X-Linked Alport Syndrome
resolves10.1056/NEJMra022296
Alport's Syndrome, Goodpasture's Syndrome, and Type IV Collagen
resolves10.1016/S0041-1345(00)02388-5
Collagen IV is upregulated in chronic transplant nephropathy
resolves10.1016/j.metabol.2009.05.025
Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats
resolves10.1053/j.ajkd.2011.04.019
Association of Urinary Type IV Collagen With GFR Decline in Young Patients With Type 1 Diabetes
resolves10.2337/dc10-0199
Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria
resolves10.1159/000319794
Urinary Type IV Collagen in Nondiabetic Kidney Disease
resolves10.1681/ASN.2008121233
Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria
resolves10.1007/s00441-012-1368-x
Transmembrane collagen XVII is a novel component of the glomerular filtration barrier
resolves10.1016/j.yexcr.2012.02.031
The glomerular basement membrane
resolves10.1007/s00441-009-0821-y
Proteoglycans: from structural compounds to signaling molecules
resolves10.1371/journal.pone.0018575
Role of Glomerular Proteoglycans in IgA Nephropathy
resolves10.1093/ndt/gfn758
Glomerular filtration is normal in the absence of both agrin and perlecan–heparan sulfate from the glomerular basement membrane
resolves10.1038/sj.ki.5002706
Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria
resolves10.2353/ajpath.2007.061116
Disruption of Glomerular Basement Membrane Charge through Podocyte-Specific Mutation of Agrin Does Not Alter Glomerular Permselectivity
resolves10.1681/ASN.2008050549
The Mesangial Cell Revisited
resolves10.1007/s00281-007-0089-9
Immunopathogenesis of IgAN
resolves10.1097/01.ASN.0000065640.77499.D7
Extracellular Matrix Metabolism in Diabetic Nephropathy
resolves10.1046/j.1523-1755.2000.00317.x
Small proteoglycans of normal adult human kidney: Distinct expression patterns of decorin, biglycan, fibromodulin, and lumican
resolves10.1053/meta.2001.28074
Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice
resolves10.1002/jcla.10099
Relationship between levels of urinary type IV collagen and renal injuries in patients with IgA nephropathy
resolves10.1159/000058345
Matrix Metalloproteinases and Their Inhibitions in Experimental Renal Scarring
resolves10.1038/labinvest.2013.42
Inhibition of collagen I accumulation reduces glomerulosclerosis by a Hic-5-dependent mechanism in experimental diabetic nephropathy
resolves10.1002/jemt.20565
Human matrix metalloproteinases: Characteristics and pathologic role in altering mesangial homeostasis
resolves10.1016/j.ydbio.2009.10.026
The extracellular matrix in development and morphogenesis: A dynamic view
resolves10.1038/ki.1993.312
Interstitial fibrosis in obstructive nephropathy
resolves10.1186/1559-0275-9-13
Urine proteome of autosomal dominant polycystic kidney disease patients
resolves10.1046/j.1523-1755.2000.00868.x
Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease
resolves10.1681/ASN.2007091025
Urinary Proteomics in Diabetes and CKD
resolves10.1093/ndt/12.9.1883
Urinary and serum type II collagen: markers of renal fibrosis
resolves10.1097/01.TP.0000066809.60389.48
Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients
resolves10.2215/CJN.06610909
Urinary Procollagen III Aminoterminal Propeptide (PIIINP)
resolves10.1172/JCI114731
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
resolves10.1046/j.1523-1755.1998.00774.x
Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat
resolves10.1242/jcs.023820
The extracellular matrix at a glance
resolves10.1038/360361a0
Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease
resolves10.1016/j.coph.2009.11.007
Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases
resolves10.1038/ki.1997.156
Increased expression of decorin in experimental hydronephrosis
resolves10.1038/nm.2989
Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis
resolves10.1681/ASN.2010050570
Small Leucine-Rich Proteoglycans in Kidney Disease
resolves10.1038/nm0496-418
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
resolves10.1152/ajpregu.00332.2011
Renal interstitial hyaluronan: functional aspects during normal and pathological conditions
resolves10.1016/S0955-0674(02)00375-7
Versican: a versatile extracellular matrix proteoglycan in cell biology
resolves10.1177/44.4.8601689
Distribution of the large aggregating proteoglycan versican in adult human tissues.
resolves10.1371/journal.pone.0044891
Increased Renal Versican Expression Is Associated with Progression of Chronic Kidney Disease
resolves10.1111/j.1440-1827.2010.02547.x
Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases
resolves10.1093/ndt/gfr583
ADAM17 up-regulation in renal transplant dysfunction and non-transplant-related renal fibrosis
resolves10.1038/sj.ki.5001753
ADAM19 expression in human nephrogenesis and renal disease: Associations with clinical and structural deterioration
resolves10.1111/j.1600-6143.2006.01384.x
Upregulation of ADAM19 in Chronic Allograft Nephropathy
resolves10.1016/j.etp.2007.01.003
Expression and significance of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 in an animal model of renal interstitial fibrosis induced by unilateral ureteral obstruction
resolves10.4103/0971-4065.101257
Hereditary ADAMTS 13 deficiency presenting as recurrent acute kidney injury
resolves10.1101/cshperspect.a005058
Extracellular Matrix Degradation and Remodeling in Development and Disease
resolves10.1016/j.cardiores.2005.12.002
Structure and function of matrix metalloproteinases and TIMPs
resolves10.1159/000339645
Urinary Matrix Metalloproteinase Activity in Diabetic Kidney Disease: A Potential Marker of Disease Progression
resolves10.2353/ajpath.2006.050896
Role for Macrophage Metalloelastase in Glomerular Basement Membrane Damage Associated with Alport Syndrome
resolves10.1152/ajprenal.00037.2012
Matrix metalloproteinases in kidney homeostasis and diseases
resolves10.1152/ajprenal.00421.2006
Role of matrix metalloproteinases in renal pathophysiologies
resolves10.1513/pats.200601-012TK
Matrix Metalloproteases in Aberrant Fibrotic Tissue Remodeling
resolves10.1074/jbc.271.25.15074
Matrix Metalloproteinase 2 (Gelatinase A) Regulates Glomerular Mesangial Cell Proliferation and Differentiation
resolves10.1159/000028023
Changes in Matrix Metalloproteinases during the Evolution of Interstitial Renal Fibrosis in a Rat Experimental Model
resolves10.1038/ki.1996.10
Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat
resolves10.1002/jcla.20024
Levels of urinary matrix metalloproteinase‐9 (MMP‐9) and renal injuries in patients with type 2 diabetic nephropathy
resolves10.1111/j.1523-1755.2004.00641.x
Matrilysin (MMP-7) expression in renal tubular damage: Association with Wnt4
resolves10.3109/1354750X.2013.789084
Quantification of “end products” of tissue destruction in inflammation may reflect convergence of cytokine and signaling pathways – implications for modern clinical chemistry
resolves10.1016/j.clinbiochem.2011.08.1135
Protein fingerprints — Relying on and understanding the information of serological protein measurements
resolves10.1089/adt.2012.474
Extracellular Matrix Remodeling: The Common Denominator in Connective Tissue Diseases <i>Possibilities for Evaluation and Current Understanding of the Matrix as More Than a Passive Architecture, but a Key Player in Tissue Failure</i>
resolves10.1016/j.clinbiochem.2011.01.001
Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM—Increased serum CIIM in subjects with severe radiographic osteoarthritis
resolves10.1111/liv.12044
Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis—a serological evaluation
resolves10.4137/BMI.S9415
Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis
resolves10.1371/journal.pone.0071050
Association of Systemic Collagen Type IV Formation with Survival among Patients Undergoing Hemodialysis
resolves10.1111/apt.12484
Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
resolves10.1186/1471-2466-12-34
Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation
resolves10.1186/1471-5945-11-6
Measurement of matrix metalloproteinase 9-mediated Collagen type III degradation fragment as a marker of skin fibrosis
resolves10.4137/BMI.S6347
Measurement of CO3-610, a Potential Liver Biomarker Derived from Matrix Metalloproteinase-9 Degradation of Collagen Type III, in a Rat Model of Reversible Carbon-Tetrachloride-Induced Fibrosis
resolves10.1371/journal.pone.0024753
MMP Mediated Degradation of Type VI Collagen Is Highly Associated with Liver Fibrosis – Identification and Validation of a Novel Biochemical Marker Assay
resolves10.1186/1755-1536-4-22
Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis
resolves10.1186/1755-1536-6-9
Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases
resolves10.1111/j.1478-3231.2010.02309.x
Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis
resolves10.3389/fphys.2013.00195
Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats
resolves10.1111/j.1872-034X.2011.00946.x
Enzyme‐linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis
resolves10.1007/s10157-004-0287-x
Effect of ureteral obstruction on matrix metalloproteinase-2 in rat renal cortex
resolves10.1046/j.1365-2168.2000.01499.x
Molecular changes in extracellular matrix turnover after renal ischaemia–reperfusion injury
resolves10.1097/00004872-200309000-00022
Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats
resolves10.1096/fj.06-5898fje
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury
resolves10.1111/j.1432-2277.2004.00053.x
Fibrosis and matrix metalloproteinases in rat renal allografts
resolves10.1159/000147926
Altered Kidney Matrix Gene Expression in Early Stages of Experimental Diabetes
resolves10.1152/ajpregu.00300.2005
Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes
resolves10.1038/ki.1996.421
Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia
resolves10.1681/ASN.V591675
Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis.
resolves10.1038/ki.2011.254
The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats
resolves10.1681/ASN.2006121343
Complement C5 Mediates Experimental Tubulointerstitial Fibrosis
resolves10.1016/0046-8177(92)90057-A
Mesangial deposition of type I collagen in human glomerulosclerosis
resolves10.1074/jbc.M102859200
Global Gene Expression Analysis Reveals a Role for the α1 Integrin in Renal Pathogenesis
resolves10.1016/S0006-291X(02)00693-9
Differential expression of type IV collagen isoforms in rat glomerular endothelial and mesangial cells
resolves10.1016/S0002-9440(10)64937-1
Absence of Decorin Adversely Influences Tubulointerstitial Fibrosis of the Obstructed Kidney by Enhanced Apoptosis and Increased Inflammatory Reaction
resolves10.2337/db06-0477
Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
resolves10.1097/00007890-199008000-00014
THE LOCALIZATION OF HYALURONAN IN NORMAL AND REJECTED HUMAN KIDNEYS
The 10 references without a DOI — listed, not checked
no DOI — not checkedU.S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2013, Bethesda, MD
no DOI — not checkedGoldsmith D, Jayawardene S, Ackland P: ABC of Kidney Disease. 2013, Chichester: John Wiley & Sons, Ltd, 2
no DOI — not checkedO’Callaghan C: The Renal System at a Glance. 2009, Chichester: John Wiley & Sons, Ltd, 3
no DOI — not checkedOkonogi H, Nishimura M, Utsunomiya Y, Hamaguchi K, Tsuchida H, Miura Y, Suzuki S, Kawamura T, Hosoya T, Yamada K: Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol. 2001, 55: 357-364.
no DOI — not checkedVleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA: Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol. 1995, 44: 211-219.
no DOI — not checkedBarascuk N, Genovese F, Larsen L, Byrjalsen I, Zheng Q, Sun S, Hosbond S, Poulsen TS, Diederichsen A, Jensen JM, Mickley H, Register TC, Rasmussen LM, Leeming DJ, Christiansen C, Karsdal MA: A MMP derived versican neo-epitope is elevated in plasma from patients with atherosclerotic heart disease. Int J Clin Exp Med. 2013, 6: 174-184.
no DOI — not checkedSharma AK, Mauer SM, Kim Y, Michael AF: Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy. J Lab Clin Med. 1995, 125: 754-761.
no DOI — not checkedBasile DP, Martin DR, Hammerman MR: Extracellular matrix-related genes in kidney after ischemic injury: potential role for TGF-beta in repair. Am J Physiol. 1998, 275: F894-F903.
no DOI — not checkedEddy AA: Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int Suppl. 1996, 54: S49-S54.
no DOI — not checkedRugheimer L, Carlsson C, Johnsson C, Hansell P: Renal hyaluronan content during experimental uncontrolled diabetes in rats. J Physiol Pharmacol. 2008, 59: 115-128.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1186/1755-1536-7-4"><img src="https://citestamp.com/citestamped/10.1186/1755-1536-7-4/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1186/1755-1536-7-4/badge.svg)](https://citestamp.com/citestamped/10.1186/1755-1536-7-4)